Biora Therapeutics, Inc. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2024-01-11: Study NCT06275464; Company role Lead sponsor; Phase Phase 1; Status Completed.
- 2019-11-22: Study NCT04204018; Company role Collaborator; Phase Not applicable; Status Completed.
- 2018-10-01: Study NCT03767803; Company role Lead sponsor; Phase Observational; Status Unknown.
- 2016-01: Study NCT02780414; Company role Lead sponsor; Phase Observational; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2024-01-11 | NCT06275464 BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects | Lead sponsor | Phase 1 | Completed | Healthy | 48 | 2024-04-23 |
| 2019-11-22 | NCT04204018 Measuring Practice Pattern Changes and Clinical Utility of a Novel Test for Preeclampsia | Collaborator Lead: Qure Healthcare, LLC | Not applicable | Completed | Pre-Eclampsia | 108 | 2019-12-23 |
| 2018-10-01 | NCT03767803 Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women | Lead sponsor | Observational | Unknown | Pre-Eclampsia; Hypertension; Proteinuria in Pregnancy; Thrombocytopenia; Renal Insufficiency; Impaired Liver Function; Pulmonary Edema; Headache; Visual Impairment | 344 | 2020-12-31 |
| 2016-01 | NCT02780414 Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers | Lead sponsor | Observational | Completed | Preeclampsia; Hypertension; Proteinuria; Thrombocytopenia; Renal Insufficiency; Impaired Liver Function; Pulmonary Edema | 1,730 | 2020-10-23 |
| 2015-10 | NCT02787486 Expanded Noninvasive Genomic Medical Assessment: The Enigma Study | Lead sponsor | Observational | Completed | Down Syndrome; Edwards Syndrome; Patau Syndrome; Klinefelter Syndrome; Turner Syndrome; DiGeorge Syndrome; Chromosome Deletion; Aneuploidy | 760 | 2018-09 |
| 2015-07 | NCT02797743 Whole Blood Specimen Collection From Healthy Subjects | Lead sponsor | Observational | Unknown | Healthy Volunteers | 750 | 2021-09 |
| 2015-03 | NCT02430584 Whole Blood Specimen Collection From Pregnant Subjects | Lead sponsor | Observational | Unknown | Down Syndrome; Edwards Syndrome; Patau Syndrome; Klinefelter Syndrome; Turner Syndrome; DiGeorge Syndrome; Perinatal Infections | 5,000 | 2021-05 |
| 2015-03 | NCT02317965 Non-Invasive Screening for Fetal Aneuploidy | Lead sponsor | Observational | Unknown | Down Syndrome; Edwards Syndrome | 340 | 2018-11 |
| 2013-01-07 | NCT01822470 Small Intestinal Bacterial Overgrowth: A Prospective Registry | Collaborator Lead: Indiana University | Observational | Enrolling by invitation | Functional Dyspepsia; Small Intestinal Bacterial Overgrowth | 200 | 2026-12 |